{"id":"https://openalex.org/W2149227806","doi":"https://doi.org/10.1517/14712598.2014.935332","title":"Amyloid-directed monoclonal antibodies for the treatment of Alzheimer\u2019s disease: the point of no return?","display_name":"Amyloid-directed monoclonal antibodies for the treatment of Alzheimer\u2019s disease: the point of no return?","alternate_titles":[],"publication_year":2014,"publication_date":"2014-06-30","ids":{"openalex":"https://openalex.org/W2149227806","doi":"https://doi.org/10.1517/14712598.2014.935332","mag":"2149227806","pmid":"https://pubmed.ncbi.nlm.nih.gov/24981190"},"language":"en","primary_location":{"id":"doi:10.1517/14712598.2014.935332","doi":"https://doi.org/10.1517/14712598.2014.935332","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14712598.2014.935332","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2149227806"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049018008","display_name":"Francesco Panza","orcid":"https://orcid.org/0000-0002-7220-0656","observed_orcids":["https://orcid.org/0000-0002-7220-0656"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francesco Panza","raw_affiliation_strings":["University of Bari Aldo Moro, Department of Basic Medicine, Neuroscience, and Sense Organs, Neurodegenerative Disease Unit , Bari , Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bari Aldo Moro, Department of Basic Medicine, Neuroscience, and Sense Organs, Neurodegenerative Disease Unit , Bari , Italy","institution_ids":["https://openalex.org/I5561750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108108635","display_name":"Vincenzo Solfrizzi","orcid":"https://orcid.org/0000-0002-8524-0315","observed_orcids":["https://orcid.org/0000-0002-8524-0315"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vincenzo Solfrizzi","raw_affiliation_strings":["University of Bari Aldo Moro, Geriatric Medicine-Memory Unit and Rare Disease Centre, Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bari Aldo Moro, Geriatric Medicine-Memory Unit and Rare Disease Centre, Bari, Italy","institution_ids":["https://openalex.org/I5561750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075804608","display_name":"Bruno Pietro Imbimbo","orcid":"https://orcid.org/0000-0002-0327-7262","observed_orcids":["https://orcid.org/0000-0002-0327-7262"]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bruno P Imbimbo","raw_affiliation_strings":["Research and Development Department, Chiesi Farmaceutici, Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Department, Chiesi Farmaceutici, Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047104019","display_name":"Giancarlo Logroscino","orcid":"https://orcid.org/0000-0003-0423-3242","observed_orcids":["https://orcid.org/0000-0003-0423-3242"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giancarlo Logroscino","raw_affiliation_strings":["University of Bari Aldo Moro, Department of Basic Medicine, Neuroscience, and Sense Organs, Neurodegenerative Disease Unit, Bari, Italy; University of Bari Aldo Moro, Department of Clinical Research in Neurology, \u201cPia Fondazione Cardinale G. Panico\u201d, Tricase, Lecce, Italy geriat.dot@geriatria.uniba.it","University of Bari Aldo Moro, Department of Basic Medicine, Neuroscience, and Sense Organs, Neurodegenerative Disease Unit,\nBari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bari Aldo Moro, Department of Basic Medicine, Neuroscience, and Sense Organs, Neurodegenerative Disease Unit, Bari, Italy; University of Bari Aldo Moro, Department of Clinical Research in Neurology, \u201cPia Fondazione Cardinale G. Panico\u201d, Tricase, Lecce, Italy geriat.dot@geriatria.uniba.it","institution_ids":["https://openalex.org/I5561750"]},{"raw_affiliation_string":"University of Bari Aldo Moro, Department of Basic Medicine, Neuroscience, and Sense Organs, Neurodegenerative Disease Unit,\nBari, Italy","institution_ids":["https://openalex.org/I5561750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9745,"has_fulltext":false,"cited_by_count":88,"citation_normalized_percentile":{"value":0.65639973,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"14","issue":"10","first_page":"1465","last_page":"1476"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.5479999780654907},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.890999972820282},{"id":"https://openalex.org/keywords/bapineuzumab","display_name":"bapineuzumab","score":0.9610000252723694},{"id":"https://openalex.org/keywords/solanezumab","display_name":"solanezumab","score":1.0},{"id":"https://openalex.org/keywords/gantenerumab","display_name":"gantenerumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/crenezumab","display_name":"crenezumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.5509999990463257},{"id":"https://openalex.org/keywords/cognitive-effects","display_name":"cognitive effects","score":0.3310000002384186},{"id":"https://openalex.org/keywords/fibrillar-amyloid-beta","display_name":"fibrillar amyloid-beta","score":0.6069999933242798},{"id":"https://openalex.org/keywords/amyloid-beta-oligomers","display_name":"amyloid-beta oligomers","score":0.828000009059906}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6710814237594604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6167877316474915},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5181523561477661},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.4918646812438965},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.46272292733192444},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45698004961013794},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.42530637979507446},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4223068654537201},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37388545274734497},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.36522892117500305},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.31080448627471924}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1517/14712598.2014.935332","doi":"https://doi.org/10.1517/14712598.2014.935332","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14712598.2014.935332","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},{"id":"pmid:24981190","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24981190","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on biological therapy","raw_type":"Journal Article"},{"id":"pmh:oai:ricerca.uniba.it:11586/39402","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11586/39402","pdf_url":null,"source":{"id":"https://openalex.org/S4377196296","display_name":"CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5561750","host_organization_name":"University of Bari Aldo Moro","host_organization_lineage":["https://openalex.org/I5561750"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":77,"referenced_works":["https://openalex.org/W1546597559","https://openalex.org/W1567490604","https://openalex.org/W1746965720","https://openalex.org/W1786559844","https://openalex.org/W1824128114","https://openalex.org/W1927066019","https://openalex.org/W1947142382","https://openalex.org/W1948376220","https://openalex.org/W1964117773","https://openalex.org/W1964464904","https://openalex.org/W1980564700","https://openalex.org/W1988404208","https://openalex.org/W1994397669","https://openalex.org/W1996788036","https://openalex.org/W2001436176","https://openalex.org/W2004535959","https://openalex.org/W2013078308","https://openalex.org/W2015484447","https://openalex.org/W2024917017","https://openalex.org/W2029794867","https://openalex.org/W2030067782","https://openalex.org/W2034135634","https://openalex.org/W2037902576","https://openalex.org/W2038629104","https://openalex.org/W2041425500","https://openalex.org/W2043715766","https://openalex.org/W2044429455","https://openalex.org/W2053571233","https://openalex.org/W2053936304","https://openalex.org/W2057771377","https://openalex.org/W2060483874","https://openalex.org/W2060829510","https://openalex.org/W2063808031","https://openalex.org/W2067766876","https://openalex.org/W2068777250","https://openalex.org/W2073271453","https://openalex.org/W2075481535","https://openalex.org/W2078212921","https://openalex.org/W2086523105","https://openalex.org/W2086572083","https://openalex.org/W2086729582","https://openalex.org/W2089443438","https://openalex.org/W2096890121","https://openalex.org/W2101209575","https://openalex.org/W2103139149","https://openalex.org/W2106931873","https://openalex.org/W2108216694","https://openalex.org/W2110630889","https://openalex.org/W2110985141","https://openalex.org/W2112579276","https://openalex.org/W2113759533","https://openalex.org/W2115017507","https://openalex.org/W2116456562","https://openalex.org/W2118753807","https://openalex.org/W2118935254","https://openalex.org/W2129497119","https://openalex.org/W2131328232","https://openalex.org/W2132154794","https://openalex.org/W2134711807","https://openalex.org/W2139481638","https://openalex.org/W2142922534","https://openalex.org/W2143238511","https://openalex.org/W2147653193","https://openalex.org/W2148034536","https://openalex.org/W2149862198","https://openalex.org/W2150231759","https://openalex.org/W2155260769","https://openalex.org/W2158854213","https://openalex.org/W2159462479","https://openalex.org/W2166976202","https://openalex.org/W2170241219","https://openalex.org/W2171250577","https://openalex.org/W2210273446","https://openalex.org/W2317946538","https://openalex.org/W2318476696","https://openalex.org/W2582524520","https://openalex.org/W4246901461"],"related_works":["https://openalex.org/W2766042976","https://openalex.org/W2171051792","https://openalex.org/W2558209914","https://openalex.org/W2144680439","https://openalex.org/W3112722171","https://openalex.org/W2051324813","https://openalex.org/W2317042575","https://openalex.org/W3048331423","https://openalex.org/W4396517761","https://openalex.org/W2139481638"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Two":[1,107],"humanized":[2],"monoclonal":[3,62,109],"antibodies,":[4,110],"bapineuzumab":[5,45],"and":[6,13,46,81,118,126],"solanezumab,":[7,44],"directed":[8],"against":[9],"the":[10,185],"N":[11],"terminus":[12],"mid-region":[14],"of":[15,84,99,187],"\u03b2-amyloid":[16],"(A\u03b2),":[17],"respectively,":[18],"were":[19],"recently":[20],"tested":[21,90,132,149],"in":[22,28,49,76,91,133,137,150,154,184],"large,":[23],"long-term":[24],"Phase":[25,50,93],"III":[26,51,94],"trials":[27,52,136,173],"patients":[29,80,86,101],"with":[30,140],"mild-to-moderate":[31],"Alzheimer's":[32],"disease":[33],"(AD).":[34],"AREAS":[35],"COVERED:":[36],"This":[37],"review":[38],"discusses":[39],"current":[40],"clinical":[41,56],"data":[42],"on":[43],"their":[47],"failure":[48],"to":[53,96,102,115,123],"show":[54],"significant":[55],"benefits,":[57],"as":[58,60],"well":[59],"other":[61,108],"antibodies":[63],"under":[64],"investigation":[65],"for":[66,165],"AD.":[67,188],"EXPERT":[68],"OPINION:":[69],"Solanezumab":[70,145],"showed":[71],"some":[72],"beneficial":[73],"cognitive":[74],"effects":[75],"mildly":[77],"affected":[78],"AD":[79,85,100,143],"this":[82,97],"subgroup":[83,98],"is":[87,146],"currently":[88],"being":[89,131,148],"another":[92],"trial":[95],"confirm":[103],"previous":[104],"encouraging":[105],"observations.":[106],"gantenerumab,":[111],"which":[112,120],"preferentially":[113,121],"binds":[114,122],"fibrillar":[116,127],"A\u03b2,":[117],"crenezumab,":[119],"soluble,":[124],"oligomeric":[125],"A\u03b2":[128,178],"deposits,":[129],"are":[130],"secondary":[134,171],"prevention":[135,152,172],"presymptomatic":[138],"subjects":[139],"autosomal":[141],"dominant":[142],"mutations.":[144],"also":[147],"a":[151,181],"study":[153],"asymptomatic":[155],"older":[156],"subjects,":[157],"who":[158],"have":[159],"positive":[160],"positron":[161],"emission":[162],"tomography":[163],"scans":[164],"brain":[166],"amyloid":[167],"deposits.":[168],"These":[169],"ongoing":[170],"will":[174],"tell":[175],"us":[176],"if":[177],"really":[179],"plays":[180],"crucial":[182],"role":[183],"pathophysiology":[186]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2149227806","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
